Skip to main content

Find Clinical Trials

Home
Conditions
Neurofibromatosis 1

Clinical trial condition

Neurofibromatosis 1

Explore clinical trials studying Neurofibromatosis 1. Study availability and eligibility vary by location and protocol.

135 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

Neurofibromatosis 1 trial results

Completed

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

NCT01125046

Conditions: Acoustic Schwannoma, Adult Anaplastic Meningioma, Adult Ependymoma, +51 more
Locations: Northwestern University Chicago, Illinois, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Columbia University Medical Center New York, United States

University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Eligibility Screening for a NCI Pediatric Oncology Branch Research Study

NCT00026780

Conditions: Acute Lymphoblastic Leukemia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ewing Sarcoma, +38 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Adaptation and Quality of Life Among Adults With Neurofibromatosis Type I

NCT00684398

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +16 more
Locations: National Human Genome Research Institute (NHGRI), 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

NCT00727233

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Genetic Evaluation of NF1 and Scoliosis Patients

NCT01776125

Conditions: Bone Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +18 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Non-invasive Stimulation in Neurofibromatosis Type 1

NCT03310996

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +13 more
Locations: University of Manchester Manchester, Greater Manchester, United Kingdom

View Trial Details

Completed

Multi-center Project: Spinal Abnormalities in Neurofibromatosis Type1 (NF1) Patients

NCT00667836

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations: Shriners Hospitals for Children, Salt Lake City Salt Lake City, Utah, United States

View Trial Details

Completed

Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia

NCT00303368

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +15 more
Locations: Shriners Hospitals for Children, Intermountain Hospital Salt Lake City, Utah, United States

View Trial Details

Completed

Internet Support Group for Parents of a Child With Neurofibromatosis Type 1

NCT02153931

Conditions: Anxiety Disorders, Behavior, Behavioral Symptoms, +18 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1

NCT02096471

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +16 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

University of Chicago Chicago, Illinois, United States

Indiana Unversity Indianapolis, Indiana, United States

View Trial Details